Protagenic Therapeutics appoints William Nichols as President; base salary $350k, 40% bonus target, 1% option grant

Protagenic Therapeutics, Inc.new

William (Bill) Nichols, Jr., age 51, appointed President effective Feb 3, 2026.
Prior senior commercial leadership roles at bluebird bio, Dova Pharmaceuticals, and Bristol-Myers Squibb.
Annual base salary $350,000; eligible for annual target bonus of 40% of base salary.
Employment agreement includes option grant equal to ~1.0% of fully diluted share count.
No family relationships or transactions requiring Item 404(a) disclosure.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.